Cold Chain Products Market for Plasma Fractionation is projected to reach USD 711 million by 2027 from USD 569 million in 2022, at a CAGR of 4.5% during the forecast period. There are several factors which drive the Cold Chain Products Market for Plasma Fractionation like Rising use of immunoglobulins and other plasma products in a range of therapeutic area, Increasing demand for Plasma-derived medicinal products, and Technological advancements in refrigeration equipment and systems.

The cold chain products industry is poised for significant growth in the near future, driven by the increasing demand for temperature-controlled storage and transportation of perishable goods. With the growth of global trade and the expansion of the pharmaceutical and food sectors, the need for reliable cold chain solutions has become paramount. Cold chain products such as refrigerated containers, cold storage warehouses, temperature monitoring devices, and packaging materials play a crucial role in maintaining the integrity and quality of temperature-sensitive products throughout the supply chain. The industry is witnessing advancements in insulation materials, refrigeration technologies, and data monitoring systems to ensure precise temperature control and real-time visibility of product conditions. Additionally, the increasing focus on sustainability and energy efficiency is driving the development of eco-friendly cold chain solutions. As the demand for cold chain products continues to rise, the industry is expected to experience innovation, collaboration, and investment to meet the evolving requirements of various sectors, ensuring the safe and efficient transportation and storage of temperature-sensitive products.

Download an Illustrative overview: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=159802939

Browse in-depth TOC on "Cold Chain Products Market"

120 - Tables
50 - Figures
200 – Pages

Key Market Players:

The prominent players in the global Cold Chain Products Market for Plasma Fractionation are B Medical Systems (US), Blue Star Limited (India), Thermo Fisher Scientific (US), Godrej and Boyce Manufacturing Co. Ltd. (India), Haier Biomedical (China), Eppendorf SE (Germany), Avantor, Inc. (US), Biolife Solutions Inc. (US), and Helmer Scientific Inc. (US).

Driver: Rising use of immunoglobulins and other plasma products in a range of therapeutic area

Immunoglobulins (IgG), also known as immune globulin or gamma globulin plays a crucial role in the treatment of primary immunodeficiency and various other conditions. Polyvalent immunoglobulins, prepared from multiple donors, are essential for addressing immunological disorders such as primary and secondary immunodeficiencies. Additionally, high-dose immunoglobulins exhibit immune-modulating effects in neurological, hematological, and dermatological immune diseases. Hyperimmune immunoglobulins with specific antibodies are utilized for preventing or treating infections like tetanus, measles, and rabies, as well as preventing hemolytic diseases in newborns. The demand for plasma fractionation is primarily driven by the clinical utilization of immunoglobulins, which has been steadily increasing and is expected to continue growing. This growing demand for plasma therapeutics, specifically immunoglobulins, in high-income countries can lead to the production of surplus amounts of other therapeutic proteins such as albumin. Consequently, the demand for cold chain products in the plasma fractionation market is projected to rise due to the increased usage of immunoglobulins and other plasma products, requiring storage equipment throughout the manufacturing and application process.

Opportunity: Demand for Plasma Fractionation Centre

The global demand for plasma-derived products is growing at a rate of approximately 7% per year due to increasing prevalence of diseases like hemophilia, immune deficiency disorders, and alpha-I antitrypsin deficiency. The United States, European Union, and China have the highest demand for these products, driven by the high prevalence of such diseases. Other regions, such as India and Africa, also require plasma fractionation centers. India's large population and high disease prevalence contribute to its demand for plasma-derived products, although the country relies on imports due to low plasma collection rates. Similarly, Africa faces limited availability of these products due to low plasma collection rates, often hindered by infrastructure and resource challenges.

"Temperature monitoring devices segment is expected to witness the fastest growth in the forecast period."

The Cold Chain Products for Plasma Fractionation market is categorized into seven types, including Ultra-low temperature freezers, Plasma freezers, Temperature monitoring devices, Plasma contact shock freezers, Blood transport boxes, Ice-lined refrigerators, and Others. Among these categories, the Temperature monitoring devices segment is projected to experience the highest growth rate from 2022 to 2027. Increased research and development investment in medical devices such as medical freezers and refrigerators are additional factors that are anticipated to drive market growth during the forecasted period

"Blood collection centers and blood component providers accounted for the largest share of the Cold Chain Products Market for Plasma Fractionation in 2021."

The Cold Chain Products Market for Plasma Fractionation is categorized into different end users, including Blood collection centers and blood component providers, Hospitals and transfusion centers, Clinical research laboratories, and Others. Among these, the Blood collection centers, and blood component providers segment held the fastest-growing market for cold chain products for plasma fractionation in 2021. This significant market share can be attributed to factors such as the increasing prevalence of diseases like hemophilia, immune deficiency disorders, and liver diseases, as well as the growing aging population.

Get 10% Free Customization on this Report: https://www.marketsandmarkets.com/requestCustomizationNew.asp?id=159802939

"North America accounted for the largest share of the Cold Chain Products Market for Plasma Fractionation in 2021"

The Cold Chain Products Market for Plasma Fractionation is segmented into five geographical regions: North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa. In 2021, North America emerged as the dominant market for Cold Chain Products for Plasma Fractionation worldwide. The increasing demand for plasma freezers and the availability of advanced cold storage devices for laboratories are expected to be major driving factors for market growth in North America. The region's substantial market share can be attributed to its well-developed healthcare infrastructure and the continuous investment in research and development of medical devices such as medical freezers and refrigerators.

Cold Chain Products Market Dynamics:

Drivers:

  1. Growing adoption of hybrid operating rooms

Restraints:

  1. Increasing adoption of refurbished medical displays

Opportunities:

  1. Increasing investments from government bodies and private players in healthcare sectors in emerging economies

Challenges:

  1. Adoption of consumer-grade displays

Recent Developments:

  • In April 2023, LG electronics launched 32HQ713D-B, which has latest high-resolution 8MP diagnostic medical monitor. It combines 1000 nits of brightness with LG's proprietary IPS Black panel to deliver an enhanced 2,000:1 contrast ratio with deep blacks, while greatly simplifying color calibration through an automatic integrated sensor and software.
  • In February 2023, Eizo launched a 21.3-inch 2-megapixel (1200 x 1600 pixels) color monitor for displaying patient charts and reviewing diagnostic imaging in hospital and clinic environments.
  • In November 2022, Barco launched two displays. Io Gray 5.8 MP for the breast imaging and MDSC-8532 and MDSC-8527 4K UHD for surgical display.
  • In July 2022, Eizo launched launched four new monitors ranging from 32 to 55 inches with 4K UHD resolution (3840 x 2160 pixels) for use in endoscopy, microsurgery, and other high-precision procedures in the operating room (OR).

Report Link: Cold Chain Products Market

Table of Content:

1 INTRODUCTION (Page No. - 22)

  • STUDY OBJECTIVES
  • MARKET DEFINITION
    • INCLUSIONS AND EXCLUSIONS

FIGURE 1 COLD CHAIN PRODUCTS MARKET FOR PLASMA FRACTIONATION SEGMENTATION

FIGURE 2 COLD CHAIN PRODUCTS MARKET FOR PLASMA FRACTIONATION, BY REGION

  • MARKET SCOPE
  • CURRENCY CONSIDERED
  • RESEARCH METHODOLOGY (Page No. - 26)
    • RESEARCH APPROACH

FIGURE 3 RESEARCH DESIGN

  • MARKET SIZE ESTIMATION

FIGURE 6 MARKET SIZE ESTIMATION: REVENUE SHARE ANALYSIS

FIGURE 7 REVENUE SHARE ANALYSIS ILLUSTRATION: THERMO FISHER SCIENTIFIC (US)

FIGURE 8 SUPPLY-SIDE ANALYSIS: COLD CHAIN PRODUCTS MARKET FOR PLASMA FRACTIONATION (2021)

FIGURE 9 COLD CHAIN PRODUCTS MARKET FOR PLASMA FRACTIONATION: BOTTOM-UP APPROACH

FIGURE 10 DRIVERS, OPPORTUNITIES, AND CHALLENGES (2022 & 2027): IMPACT ON MARKET GROWTH AND CAGR

  • LIMITATIONS
  • MARKET SHARE ANALYSIS
  • EXECUTIVE SUMMARY (Page No. - 39)

FIGURE 14 COLD CHAIN PRODUCTS MARKET FOR PLASMA FRACTIONATION, BY TYPE, 2022 VS. 2027 (USD MILLION)

FIGURE 15 COLD CHAIN PRODUCTS MARKET FOR PLASMA FRACTIONATION, BY END USER, 2022 VS. 2027 (USD MILLION)

FIGURE 16 COLD CHAIN PRODUCTS MARKET FOR PLASMA FRACTIONATION: GEOGRAPHIC SNAPSHOT

  • PREMIUM INSIGHTS (Page No. - 42)
    • COLD CHAIN PRODUCTS FOR PLASMA FRACTIONATION: MARKET OVERVIEW
    • ASIA PACIFIC: COLD CHAIN PRODUCTS FOR PLASMA FRACTIONATION, BY TYPE & COUNTRY (2021)
    • COLD CHAIN PRODUCTS FOR PLASMA FRACTIONATION: GEOGRAPHIC GROWTH OPPORTUNITIES
    • COLD CHAIN PRODUCTS FOR PLASMA FRACTIONATION: GEOGRAPHIC MIX
    • COLD CHAIN PRODUCTS FOR PLASMA FRACTIONATION: DEVELOPING VS. DEVELOPED COUNTRIES
  • MARKET OVERVIEW (Page No. - 46)
    • INTRODUCTION
    • MARKET DYNAMICS

FIGURE 22 COLD CHAIN PRODUCTS MARKET FOR PLASMA FRACTIONATION: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES